Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-29

Clinical Trial Update: MRONJ and Polynucleotides-Hyaluronic Acid Hydrogel (Regenfast®) [NA]

View source ↗

Summary

This entry reports a clinical trial investigating Regenfast®, a polynucleotides-hyaluronic acid hydrogel, for medication-related osteonecrosis of the jaw, curre…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Regenfast®

Snippet

Sponsor: Fondazione Policlinico Universitario Agostino Gemelli IRCCS | Conditions: Medication Related Osteonecrosis of the Jaw | NA | Status: NOT_YET_RECRUITING